BFM
RGLS

Boothbay Fund Management’s Regulus Therapeutics RGLS Stock Holding History

Boothbay Fund Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,583
Closed -$24K – 2547
2022
Q2 		$24K Sell
11,583
-823
-7% -$2K ﹤0.01% 2179
2022
Q1 		$37K Hold
12,406
– – ﹤0.01% 2204
2021
Q4 		$39K Hold
12,406
– – ﹤0.01% 1786
2021
Q3 		$86K Sell
12,406
-1,757
-12% -$12.9K ﹤0.01% 1814
2021
Q2 		$115K Hold
14,163
– – ﹤0.01% 1721
2021
Q1 		$221K Buy
+14,163
New +$210K 0.01% 1322

Other funds holding RGLS

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return